BarbriSFCourseDetails
  • videocam Live Webinar with Live Q&A
  • calendar_month February 24, 2026 @ 1:00 p.m. ET./10:00 a.m. PT
  • signal_cellular_alt Intermediate
  • card_travel Insurance
  • schedule 90 minutes

Insurance for Cannabis Businesses: Impact of Reclassification to Schedule III Status; Managing New Risks

Early Bird Pricing!
MSRP
$297.00
$252.45
Save $44.55

Discount expires 2/12/26

This course is $0 with these passes:

CLE
ALL
  1. keyboard_arrow_leftBack
BarbriPdBannerMessage

About the Course

Introduction

This CLE course will analyze the impact of reclassifying marijuana as a Class III substance under the Controlled Substances Act (CSA) on the availability and scope of insurance coverage for cannabis-related businesses. The speakers will address how the cannabis insurance market has evolved and offer practical guidance on obtaining insurance and addressing claims-related issues.

Description

Cannabis businesses need the same type of comprehensive, affordable coverage as other businesses but the gap between federal and state regulation has left these businesses with fewer and often very restrictive options for liability, business interruption, D&O, and other insurance products. Recent developments at the federal level signal that more options may be forthcoming.

Executive Order 14370 was signed on Dec. 18, 2025, instructing Congress to expedite the reclassification of cannabis from a Class I to a Class III substance under the CSA. This makes marijuana a prescription drug, but does not make it legal. When rescheduling occurs, cannabis businesses can reap tax benefits that should increase profits, cash flow, and company valuation, and increase access to capital and banking services. These changes are expected to open up newer and more traditional insurance products to cannabis and cannabis-related businesses.

Listen as our esteemed panel discusses the anticipated changes to insurance for cannabis-related businesses and offers practical guidance on obtaining insurance and addressing claims-related matters.

Presented By

Jonathan S. Robbins
Chair, Cannabis Practice
Akerman LLP

Mr. Robbins serves as chair of Akerman’s Cannabis Practice, counseling clients on the evolving, complex legal and business issues impacting companies with interests in the regulated substances industries. Ranked by Chambers USA as a top lawyer in Cannabis Law and recognized in 2018 by the National Law Journal as one of the country’s “Cannabis Law Trailblazers,” he has been published and quoted in national media outlets such as U.S. News & World Report, The American Lawyer, Politico, Washington Post, Bloomberg News, and Law360. He is a founding board member of the National Cannabis Bar Association and is also an active member of the National Cannabis Industry Association. Mr. Robbins brings deep experience representing public and private companies and individuals in complex regulatory and litigation matters in the regulated substances sectors. His experience encompasses investigations and administrative and enforcement proceedings brought by federal, state, and self-regulatory bodies, including the U.S. Securities and Exchange Commission (SEC), Florida Attorney General’s Office, Florida Department of Financial Services, and Florida Office of Insurance Regulation.

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Amy Rubenstein
Partner
Dentons Law Firm

Ms. Rubenstein delivers thoughtful, pragmatic, and actionable legal guidance by listening to clients and bridging pathways to their goals. Throughout her two-decade career, she has crafted innovative legal solutions across highly regulated, ever-evolving industries (cannabis, chemical, pharmaceutical, insurance, manufacturing, and food & beverage). In 2019 and 2021, Ms. Rubenstein was included in The Legal 500 US. Amy was selected by Super Lawyers as a Rising Star from 2011 to 2018, and by Leading Lawyers as an Emerging Lawyer from 2015 to 2017, distinctions reserved for less than 3 percent of Illinois attorneys. Additionally, the Northern District of Illinois and Federal Bar Association have recognized her work with the Award for Excellence in Pro Bono and Public Interest Service. She frequently authors articles for The National Law Review and Law360.

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Credit Information

  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Tuesday, February 24, 2026

  • schedule

    1:00 p.m. ET./10:00 a.m. PT

I. Evolution of the cannabis industry and insurance products

II. Understanding the reclassification process

III. Insurance market impacts

A. First-party property coverage litigation

B. Products liability coverage litigation

C. Miscellaneous cannabis-related insurance issues and practical considerations


The panel will review these and other high-priority issues:

  • What types of coverage are most likely to become available first?
  • Will the primary cannabis-related insurance coverage issues change after reclassification?
  • What are best practices for insurance procurement and claims-related issues?